NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $202,348 | -51.2% | 2,230 | -54.5% | 0.02% | -46.5% |
| Q2 2022 | $415,000 | -3.5% | 4,904 | +0.1% | 0.04% | +10.3% |
| Q1 2022 | $430,000 | -3.2% | 4,898 | -3.6% | 0.04% | +18.2% |
| Q4 2021 | $444,000 | +6.7% | 5,081 | -0.1% | 0.03% | -2.9% |
| Q3 2021 | $416,000 | -10.7% | 5,086 | -0.5% | 0.03% | -12.8% |
| Q2 2021 | $466,000 | +11.5% | 5,111 | +4.5% | 0.04% | +2.6% |
| Q1 2021 | $418,000 | -12.4% | 4,889 | -3.2% | 0.04% | -19.1% |
| Q4 2020 | $477,000 | -1.2% | 5,051 | -9.1% | 0.05% | -13.0% |
| Q3 2020 | $483,000 | +1.0% | 5,554 | +1.5% | 0.05% | -5.3% |
| Q2 2020 | $478,000 | +4.4% | 5,473 | -1.5% | 0.06% | -10.9% |
| Q1 2020 | $458,000 | -54.7% | 5,556 | -47.9% | 0.06% | +20.8% |
| Q4 2019 | $1,010,000 | +240.1% | 10,671 | +212.6% | 0.05% | +32.5% |
| Q3 2019 | $297,000 | – | 3,414 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |